Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: ILMN GH TXG CRSP QGEN TWST CDNA FLGT ONC FATE

| Held by: ARKK VTI ARKG IWM VXF IWN IBB VTWO SCHA PRFZ

Index	RUT	P/E	-	EPS (ttm)	-1.83	Insider Own	10.17%	Shs Outstand	301.96M	Perf Week	-5.26%
Market Cap	380.52M	Forward P/E	-	EPS next Y	-0.48	Insider Trans	-2.32%	Shs Float	271.28M	Perf Month	-29.21%
Enterprise Value	803.41M	PEG	-	EPS next Q	-0.14	Inst Own	57.83%	Short Float	15.26%	Perf Quarter	-32.98%
Income	-546.38M	P/S	2.38	EPS this Y	71.52%	Inst Trans	5.80%	Short Ratio	5.99	Perf Half Y	3.28%
Sales	160.00M	P/B	71.15	EPS next Y	7.72%	ROA	-53.45%	Short Interest	41.39M	Perf YTD	-32.62%
Book/sh	0.02	P/C	1.36	EPS next 5Y	38.83%	ROE	-213.45%	52W High	2.73 -53.85%	Perf Year	1.61%
Cash/sh	0.93	P/FCF	-	EPS past 3/5Y	-9.18% -	ROIC	-77.25%	52W Low	0.85 48.04%	Perf 3Y	-86.48%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	7.64% 15.19%	Gross Margin	-196.47%	Volatility	6.40% 6.52%	Perf 5Y	-95.90%
Dividend TTM	-	EV/Sales	5.02	EPS Y/Y TTM	-61.50%	Oper. Margin	-330.95%	ATR (14)	0.11	Perf 10Y	-84.65%
Dividend Ex-Date	-	Quick Ratio	4.47	Sales Y/Y TTM	3.89%	Profit Margin	-341.47%	RSI (14)	34.76	Recom	2.33
Dividend Gr. 3/5Y	- -	Current Ratio	5.15	EPS Q/Q	71.82%	SMA20	-9.65%	Beta	2.32	Target Price	2.36
Payout	-	Debt/Eq	131.29	Sales Q/Q	13.82%	SMA50	-28.44%	Rel Volume	1.26	Prev Close	1.35
Employees	485	LT Debt/Eq	131.21	Earnings	Feb 12 AMC	SMA200	-24.19%	Avg Volume	6.91M	Price	1.26
IPO	Oct 27, 2010	Option/Short	Yes / Yes	EPS/Sales Surpr.	9.53% 3.74%	Trades		Volume	8,681,416	Change	-6.67%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-06-26	Downgrade	Barclays	Equal Weight → Underweight	$1.50
Nov-11-24	Downgrade	UBS	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Buy	$4
Apr-22-24	Downgrade	JP Morgan	Overweight → Neutral
Apr-18-24	Downgrade	Goldman	Buy → Neutral	$7 → $2.50
Dec-14-23	Initiated	Stephens	Overweight	$11
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-17-23	Upgrade	UBS	Neutral → Buy	$13 → $10
Oct-31-23	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$11
Sep-28-23	Initiated	Bernstein	Outperform	$11
Jul-05-23	Resumed	JP Morgan	Overweight	$13
Jun-30-23	Initiated	Goldman	Buy	$17
May-10-23	Initiated	Barclays	Equal Weight	$14
Mar-31-23	Upgrade	TD Cowen	Market Perform → Outperform	$13 → $15
Feb-02-23	Initiated	UBS	Neutral	$13
Jan-20-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$12
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$12
Jan-21-22	Resumed	Cantor Fitzgerald	Overweight	$62 → $31
Jan-06-22	Resumed	Piper Sandler	Neutral	$20

Show Previous Ratings

Mar-18-26 09:05AM	Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative (GlobeNewswire)
Mar-06-26 02:00PM	PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know (StockStory) -9.21%
09:14AM	COO Declines Despite Q1 Earnings Beat and Raised FY26 Outlook (Zacks) -9.21%
Mar-05-26 10:57AM	Clover Health Enters Collaboration to Be Part of CMS Aligned Network (Zacks)
10:56AM	Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now (Zacks)
08:30AM	Loading…
08:30AM	PacBio Announces the Appointment of Chris Gibson to the Board of Directors (GlobeNewswire)
Mar-04-26 09:20AM	Here's Why You Should Retain Revvity Stock in Your Portfolio for Now (Zacks)
07:52AM	Intuitive Surgical Expands Direct Operational Presence in Europe (Zacks)
Mar-03-26 10:33PM	Life Sciences Tools & Services Stocks Q4 Recap: Benchmarking PacBio (NASDAQ:PACB) (StockStory) -6.17%
10:15AM	PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub (Zacks) -6.17%
Feb-27-26 04:15PM	PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know (StockStory) -5.62%
Feb-25-26 11:50AM	TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates (Zacks)
Feb-24-26 03:10PM	Why Is PacBio (PACB) Stock Soaring Today (StockStory) +5.06%
09:05AM	PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research (GlobeNewswire) +5.06%
Feb-20-26 10:48AM	Genomics Stocks That Deserve a Place in Your Portfolio in 2026 (Zacks)
11:01PM	Loading…
Feb-19-26 11:01PM	PacBio (PACB): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
12:35AM	5 Must-Read Analyst Questions From PacBio's Q4 Earnings Call (StockStory)
Feb-18-26 04:05PM	PacBio to Participate in the TD Cowen 46th Annual Health Care Conference (GlobeNewswire)
Feb-13-26 10:24AM	PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up (Zacks) -7.07%
08:30AM	Pacific Biosciences of California, Inc. Q4 2025 Earnings Call Summary (Moby) -7.07%
08:21AM	PACB Q4 Deep Dive: Consumables and Clinical Adoption Drive Growth as SparkNex Launch Nears (StockStory) -7.07%
12:03AM	Pacific Biosciences of California Inc (PACB) Q4 2025 Earnings Call Highlights: Strong Revenue ... (GuruFocus.com) -7.07%
Feb-12-26 08:14PM	Pacific Biosciences of California Q4 Earnings Call Highlights (MarketBeat)
05:35PM	Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates (Zacks) -7.07%
04:56PM	PacBio (NASDAQ:PACB) Reports Strong Q4 CY2025 (StockStory) -7.07%
04:40PM	Pacific Biosciences: Q4 Earnings Snapshot (Associated Press Finance) -7.07%
04:05PM	PacBio Announces Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire) -7.07%
07:00AM	PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner (GlobeNewswire)
Feb-10-26 10:04PM	PacBio Earnings: What To Look For From PACB (StockStory)
Feb-02-26 09:05AM	PacBio Completes Sale of Short-Read Sequencing Assets (GlobeNewswire) -8.85%
06:15PM	Loading…
Jan-30-26 06:15PM	Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader Market (Zacks)
Jan-27-26 04:05PM	PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 (GlobeNewswire) -7.39%
Jan-23-26 06:15PM	Pacific Biosciences of California (PACB) Stock Dips While Market Gains: Key Facts (Zacks)
Jan-16-26 06:15PM	Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know (Zacks) -5.96% +6.79%
Jan-15-26 10:35AM	PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research (Zacks)
Jan-12-26 09:15AM	PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases (GlobeNewswire)
09:05AM	PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC) (GlobeNewswire)
09:05AM	PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue (GlobeNewswire)
Jan-09-26 11:20AM	PacBio Stock Dips Post Latest Launch to Expand Multiomics Capabilities (Zacks)
Jan-08-26 11:01PM	3 Reasons to Sell PACB and 1 Stock to Buy Instead (StockStory)
09:05AM	PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell (GlobeNewswire)
Jan-07-26 06:15PM	Pacific Biosciences of California (PACB) Gains As Market Dips: What You Should Know (Zacks)
12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio (Zacks)
Jan-06-26 07:06AM	Three Genomics Stocks Worth Tracking This Year (Zacks) +5.05%
Jan-05-26 12:23PM	ARK Invest Boosts Gene-Editing Bets While Cutting Consumer Tech Exposure (GuruFocus.com) +7.61%
Jan-02-26 11:01AM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
08:00AM	Stocks making big moves this week: PacBio, Crocs, FuelCell Energy, AMC Entertainment, and ON24 (StockStory)
Dec-31-25 05:00PM	Why Is PacBio (PACB) Stock Soaring Today (StockStory) +8.09%
06:26AM	Cathie Wood Doubles Down on Biotech as 2025 Ends, Offloads Rocket Lab (GuruFocus.com) +8.09%
Dec-30-25 11:49PM	Barclays Analyst Is Bullish On Pacific Biosciences of California, Inc. (PACB) (Insider Monkey)
04:05PM	PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +8.09%
Dec-29-25 12:51PM	TSLA: Cathie Wood Dumps $30 Million Worth Tesla Stock (GuruFocus.com)
Dec-03-25 03:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory)
Nov-28-25 09:05AM	PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-26-25 09:40AM	Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? (Zacks) -9.13%
Nov-24-25 01:00PM	PacBio, Bristol-Myers Squibb, Oscar Health, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know (StockStory) +12.61%
Nov-18-25 08:48AM	Top 3 Genomics Stocks to Consider for Your Portfolio (Zacks) +5.10%
Nov-13-25 04:05PM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) -6.32%
12:00PM	Pacific Biosciences (PACB) Upgraded to Buy: Here's Why (Zacks) -6.32%
Nov-12-25 03:20PM	Why PacBio (PACB) Shares Are Getting Obliterated Today (StockStory) -6.45%
12:36AM	5 Revealing Analyst Questions From PacBio's Q3 Earnings Call (StockStory) -6.45%
Nov-11-25 12:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory) +5.68%
Nov-10-25 10:35PM	Spotting Winners: PacBio (NASDAQ:PACB) And Life Sciences Tools & Services Stocks In Q3 (StockStory)
Nov-06-25 01:19PM	PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y (Zacks) -7.05%
12:33AM	PACB Q3 Deep Dive: Consumable Strength Offsets Instrument Headwinds, Clinical Expansion in Focus (StockStory) -7.05%
Nov-05-25 06:30PM	Compared to Estimates, Pacific Biosciences (PACB) Q3 Earnings: A Look at Key Metrics (Zacks)
05:55PM	Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue Estimates (Zacks) -7.05%
04:54PM	Pacific Biosciences: Q3 Earnings Snapshot (Associated Press Finance) -7.05%
04:10PM	PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q3 Earnings (StockStory) -7.05%
04:02PM	PacBio Announces Third Quarter 2025 Financial Results (GlobeNewswire) -7.05%
09:05AM	HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes (GlobeNewswire)
Nov-04-25 09:15AM	Pacific Biosciences (PACB) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks) -10.71%
09:05AM	PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China (GlobeNewswire) -10.71%
Nov-03-25 10:07PM	PacBio Earnings: What To Look For From PACB (StockStory)
Oct-31-25 02:11PM	PacBio (PACB) Shares Skyrocket, What You Need To Know (StockStory) +20.62%
Oct-28-25 06:15PM	Pacific Biosciences of California (PACB) Stock Drops Despite Market Gains: Important Facts to Note (Zacks) -5.74%
Oct-24-25 02:36PM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
Oct-22-25 04:05PM	PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025 (GlobeNewswire) +5.98%
Oct-21-25 06:15PM	Pacific Biosciences of California (PACB) Stock Moves -4.04%: What You Should Know (Zacks)
Oct-20-25 10:10AM	PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations (Zacks) +20.73%
Oct-14-25 06:15PM	Pacific Biosciences of California (PACB) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks) +9.43%
06:05AM	PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities (GlobeNewswire)
Oct-13-25 12:22PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +14.08%
09:05AM	PacBio HiFi Technology Selected as Core Platform for South Korea's National Pangenome Project (GlobeNewswire) +14.08%
Oct-10-25 10:02AM	Here's Why You Should Retain PacBio Stock in Your Portfolio for Now (Zacks) -7.19%
Oct-08-25 12:44PM	PacBio Stock Dips Despite Announcing Expanded Partnership With seqWell (Zacks) +7.86%
11:36AM	Why Is PacBio (PACB) Stock Soaring Today (StockStory) +7.86%
09:05AM	Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity (GlobeNewswire) +7.86%
Oct-07-25 09:05AM	PacBio Expands Partnership with seqWell to Bring Scalable Long Read Sample Prep to More Labs (GlobeNewswire) -7.89%
Oct-06-25 06:15PM	Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today (Zacks)
Sep-30-25 10:05AM	PacBio Enters Carrier Screening Market With PureTarget Expansion (Zacks)
Sep-22-25 06:15PM	Pacific Biosciences of California (PACB) Rises Higher Than Market: Key Facts (Zacks)
09:05AM	PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes (GlobeNewswire)
Sep-19-25 12:03AM	3 Reasons PACB is Risky and 1 Stock to Buy Instead (StockStory)
Sep-15-25 11:46AM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
Sep-14-25 11:36PM	Life Sciences Tools & Services Stocks Q2 Teardown: PacBio (NASDAQ:PACB) Vs The Rest (StockStory)
Sep-12-25 06:15PM	Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today (Zacks)
Sep-05-25 12:30PM	PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq (Zacks)
Sep-03-25 09:05AM	PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow (GlobeNewswire)
Aug-22-25 02:25PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory)

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
HENRY CHRISTIAN O	See Remarks	Mar 03 '26	Sale	1.51	12,497	18,920	3,581,813	Mar 04 05:55 PM
Van Oene Mark	See Remarks	Mar 03 '26	Sale	1.51	6,504	9,847	2,243,634	Mar 04 05:54 PM
Farmer Michele	See Remarks	Mar 03 '26	Sale	1.51	2,979	4,510	305,948	Mar 04 05:54 PM
MARK D. VAN OENE	Officer	Mar 03 '26	Proposed Sale	1.51	6,504	9,849		Mar 03 04:24 PM
CHRISTIAN HENRY	Officer	Mar 03 '26	Proposed Sale	1.51	12,497	18,924		Mar 03 04:20 PM
Van Oene Mark	See Remarks	Feb 17 '26	Sale	1.58	129,790	204,549	1,797,745	Feb 19 08:33 PM
Van Oene Mark	See Remarks	Feb 18 '26	Sale	1.63	55,107	89,769	1,742,638	Feb 19 08:33 PM
HENRY CHRISTIAN O	See Remarks	Feb 17 '26	Sale	1.58	331,793	522,906	2,814,374	Feb 19 08:31 PM
HENRY CHRISTIAN O	See Remarks	Feb 18 '26	Sale	1.63	140,874	229,484	2,673,500	Feb 19 08:31 PM
Farmer Michele	See Remarks	Feb 17 '26	Sale	1.58	35,215	55,499	234,044	Feb 19 08:28 PM
Farmer Michele	See Remarks	Feb 18 '26	Sale	1.63	14,952	24,357	219,092	Feb 19 08:28 PM
MARK VAN OENE	Officer	Feb 17 '26	Proposed Sale	1.58	303,739	478,693		Feb 17 06:27 PM
CHRISTIAN HENRY	Officer	Feb 17 '26	Proposed Sale	1.58	606,312	955,548		Feb 17 06:25 PM
Van Oene Mark	See Remarks	Aug 18 '25	Sale	1.31	26,836	35,182	1,920,035	Aug 20 04:06 PM
MARK VAN OENE	Officer	Aug 18 '25	Proposed Sale	1.31	26,836	35,174		Aug 18 04:07 PM
Farmer Michele	See Remarks	May 19 '25	Sale	1.00	5,195	5,200	269,259	May 21 04:09 PM

Open in Screener

MRNA

Moderna Inc

Mar 27 • 04:00PM ET

49.56

-4.01 -7.49 %

Healthcare • Biotechnology • USA • NASD

Peers: BNTX NVAX REGN ALNY INCY BMRN SRPT VRTX GILD BIIB

| Held by: VTI VOO VB VBR IVV SPY RSP IBB XLV FBT

Index	S&P 500	P/E	-	EPS (ttm)	-7.26	Insider Own	8.54%	Shs Outstand	394.00M	Perf Week	-3.54%
Market Cap	19.57B	Forward P/E	-	EPS next Y	-4.59	Insider Trans	-0.58%	Shs Float	361.21M	Perf Month	-4.16%
Enterprise Value	15.08B	PEG	-	EPS next Q	-2.03	Inst Own	79.46%	Short Float	18.32%	Perf Quarter	51.33%
Income	-2.82B	P/S	10.07	EPS this Y	12.01%	Inst Trans	6.80%	Short Ratio	5.92	Perf Half Y	101.38%
Sales	1.94B	P/B	2.26	EPS next Y	28.08%	ROA	-21.31%	Short Interest	66.19M	Perf YTD	68.06%
Book/sh	21.95	P/C	3.37	EPS next 5Y	26.32%	ROE	-28.87%	52W High	59.55 -16.78%	Perf Year	54.30%
Cash/sh	14.69	P/FCF	-	EPS past 3/5Y	- -29.93%	ROIC	-28.47%	52W Low	22.28 122.44%	Perf 3Y	-66.59%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-53.32% 19.33%	Gross Margin	44.29%	Volatility	5.08% 6.57%	Perf 5Y	-62.82%
Dividend TTM	-	EV/Sales	7.76	EPS Y/Y TTM	21.76%	Oper. Margin	-158.13%	ATR (14)	3.29	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.22	Sales Y/Y TTM	-39.93%	Profit Margin	-145.16%	RSI (14)	46.07	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.29	EPS Q/Q	27.57%	SMA20	-6.68%	Beta	1.30	Target Price	42.74
Payout	-	Debt/Eq	0.15	Sales Q/Q	-29.81%	SMA50	1.97%	Rel Volume	0.63	Prev Close	53.57
Employees	4700	LT Debt/Eq	0.15	Earnings	Feb 13 BMO	SMA200	49.79%	Avg Volume	11.18M	Price	49.56
IPO	Dec 07, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.07% 6.75%	Trades		Volume	7,085,047	Change	-7.49%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-28-26	Resumed	Barclays	Equal Weight	$25
Jan-07-26	Resumed	UBS	Neutral	$34
Dec-12-25	Initiated	Jefferies	Hold	$30
Mar-13-25	Initiated	Citigroup	Neutral	$40
Feb-18-25	Downgrade	Barclays	Overweight → Equal Weight	$111 → $45
Jan-29-25	Downgrade	Goldman	Buy → Neutral	$99 → $51
Dec-18-24	Downgrade	Argus	Buy → Hold
Dec-10-24	Resumed	BofA Securities	Underperform	$41
Nov-19-24	Initiated	Berenberg	Hold	$42
Nov-18-24	Upgrade	HSBC Securities	Hold → Buy	$58
Nov-15-24	Initiated	Wolfe Research	Underperform	$40
Oct-17-24	Initiated	Bernstein	Mkt Perform	$55
Sep-13-24	Downgrade	Oppenheimer	Outperform → Perform
Sep-13-24	Downgrade	JP Morgan	Neutral → Underweight	$88 → $70
Sep-13-24	Downgrade	Jefferies	Buy → Hold	$120 → $65
Aug-28-24	Upgrade	HSBC Securities	Reduce → Hold	$82
Aug-07-24	Upgrade	Deutsche Bank	Sell → Hold	$85 → $80
Aug-05-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$125 → $90
Feb-26-24	Downgrade	HSBC Securities	Hold → Reduce	$75 → $86
Jan-02-24	Upgrade	Oppenheimer	Perform → Outperform	$142

Show Previous Ratings

Mar-26-26 07:30AM	America is handing its mRNA lead to Chinaand RFK Jr. is to blame (Fortune)
Mar-24-26 07:51AM	S&P 500 Sinks Into Red -- These Seven Stocks Are Soaring Triple Digits (GuruFocus.com)
Mar-19-26 12:18PM	Xbow Raises $120 Million, Hits $1 Billion Valuation in AI Cybersecurity Push (GuruFocus.com)
Mar-17-26 08:06AM	Biotechs Breathe Easy As Vinay Prasad Plans His Exit. But Should They? (Investor's Business Daily)
Mar-16-26 04:03PM	Covid Vaccine Maker BioNTech Offers Cheap Biotech Play Given Huge Cash Reserves (Barrons.com)
05:05PM	Loading…
Mar-15-26 05:05PM	Man's dog was riddled with tumors and dying. He used ChatGPT to design a custom cancer vaccine, stunning researchers (Moneywise)
Mar-13-26 07:54AM	GSKs RSV vaccine wins broader FDA clearance (BioPharma Dive)
Mar-10-26 11:01AM	Kohl's Q4 sales miss, EV maker NIO reports first quarterly profit (Yahoo Finance Video)
09:24AM	BioNTech Reports Earnings. That's Not Why the Stock Is Down 17%. (Barrons.com)
08:40AM	BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture (Benzinga)
08:19AM	BioNTechs Founding Duo Will Leave to Start New mRNA Firm (Bloomberg)
Mar-09-26 04:37PM	This biotech's stock soared after a 'polarizing' FDA official is stepping down (MarketWatch)
01:32PM	What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday? (Benzinga)
10:11AM	Stocks to Watch Monday: Boeing, Live Nation, Moderna, United Machines (The Wall Street Journal)
07:01AM	Why Is uniQure Stock Skyrocketing Monday? (Benzinga)
10:25PM	Loading…
Mar-08-26 10:25PM	Corrections & Amplifications (The Wall Street Journal)
Mar-07-26 12:41AM	Controversial FDA Vaccines Chief Vinay Prasad To Leave Agency In April (Benzinga)
Mar-06-26 06:05PM	Moderna Pops As Vinay Prasad, The FDA's Controversial Vaccine Head, Will Depart In April (Investor's Business Daily)
08:30AM	These 3 Stocks Just Bounced From Lows What Wall Street Thinks Comes Next (24/7 Wall St.)
Mar-05-26 12:33PM	Moderna pays up to $2.25bn to settle drug delivery tech patent lawsuit (Pharmaceutical Technology)
08:41AM	Reddit Traders Are Cheering Moderna While Bears Watch the Cash Burn (24/7 Wall St.)
06:32AM	Stocks Slip Before the Open as Bond Yields Climb on Inflation Worries, U.S. Economic Data on Tap (Barchart)
Mar-04-26 08:00PM	Moderna (MRNA) Climbs 16% as Arbutus-Genevant Legal Battle Clears (Insider Monkey)
07:55PM	Review & Preview: Stocks Show Resilience (Barrons.com)
05:10PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:50PM	These Stocks Are Todays Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More (Barrons.com)
04:33PM	Stocks Settle Higher as US Economic Resilience Overshadows Iran Conflict (Barchart)
04:32PM	Moderna Stock Shoots Up on $2.3 Billion Patent Settlement (The Wall Street Journal)
04:04PM	Moderna Stock Pops After Inking $950 Million Covid Vaccine Settlement (Investor's Business Daily)
04:00PM	Why Moderna (MRNA) Stock Is Trading Up Today (StockStory)
02:41PM	Loading…
02:41PM	Analyst Report: Moderna, Inc. (Morningstar Research)
02:35PM	Moderna Settles a Covid Vaccine Patent Lawsuit. What It Means for the Stock. (Barrons.com)
02:27PM	Moderna reaches vaccine settlement, GitLab's guidance disappoints (Yahoo Finance Video)
12:48PM	Iran Diplomacy Hopes, Bitcoin Surge Power Relief Rally: What's Moving Markets Wednesday? (Benzinga)
12:31PM	Stock Market Today: Dow, Nasdaq Higher; Bitcoin Surges On Trump News (Live Coverage) (Investor's Business Daily)
11:35AM	When Fear Hits the Stock Market, Where Can Investors Find Safety? (Barchart)
11:20AM	Stock Market Today: Dow Higher Amid Iran, Trump Tariff News; Moderna Soars (Live Coverage) (Investor's Business Daily)
11:19AM	Stocks Rally as US Economic Strength Outweighs Iran War Concerns (Barchart)
10:18AM	Moderna to pay up to $2.25B to settle COVID vaccine patent matter (Proactive)
10:10AM	Moderna Stock Boosted by $2.25 Billion Patent Settlement (The Wall Street Journal)
10:06AM	Moderna will pay up to $2.25B to end COVID vaccine patent fight (Delaware Online \| The News Journal)
09:55AM	MRNA Stock Gains on $2.25B Deal to Settle Patent Dispute With ROIV, ABUS (Zacks)
09:34AM	Stocks to Watch Wednesday: Coinbase, CrowdStrike, Gitlab, Moderna (The Wall Street Journal)
09:01AM	Moderna Pops After Inking $950 Million Covid Vaccine Settlement (Investor's Business Daily)
08:52AM	Moderna shares jump as settlement removes major legal overhang (Investing.com)
08:40AM	Moderna and Ross Stores Lead Stock Gainers on Wednesday (24/7 Wall St.)
08:14AM	Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars (Benzinga)
08:14AM	Moderna Just Settled a Lawsuit. What It Means for the Stock. (Barrons.com)
06:13AM	Moderna shares pop, and other early market movers (MarketWatch)
06:08AM	These Stocks Are Today's Movers: Moderna, CrowdStrike, GitLab, Coinbase, Strategy, Broadcom, and More (Barrons.com)
05:25AM	Moderna Stock Rallies. This Big Risk Just Got Eliminated. (Barrons.com)
02:55AM	What 3 recent FDA rejections reveal about shifts inside the agency (Pharma Voice)
Mar-03-26 08:49PM	CrowdStrike, Mobix Labs, Micron Technology, Target And Moderna: Why These 5 Stocks Are On Investors' Radars Today (Benzinga)
05:30PM	Moderna's stock rallies more than 10% as deal over a patent dispute clears vaccine pipeline (MarketWatch)
04:46PM	Moderna to Pay $950 Million to Settle Patent Cases From Arbutus, Genevant (The Wall Street Journal)
Mar-02-26 07:49AM	MRNA Stock Gains After CHMP Endorses COVID-19-Influenza Combo Shot (Zacks)
Feb-27-26 07:02PM	Analyst Report: Moderna, Inc. (Morningstar Research)
07:23AM	Modernas Covid-Flu Vaccine Recommended for Approval in EU (The Wall Street Journal)
07:00AM	European Medicines Agency's Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19 (ACCESSWIRE)
06:45AM	Modernas combination flu, COVID shot wins over European drug regulators (BioPharma Dive)
Feb-25-26 11:08AM	FDA reversal on mRNA-1010 could transform the seasonal influenza vaccines market (Clinical Trials Arena)
Feb-24-26 11:01PM	3 Reasons to Avoid MRNA and 1 Stock to Buy Instead (StockStory)
02:52AM	Will the FDA yank mRNA vaccines? (Pharma Voice)
Feb-23-26 12:50PM	Moderna Stock Is Trading Higher Today: What's Going On? (Benzinga)
Feb-22-26 09:05AM	Moderna, Coinbase, And Global Payments Are Among the Top 10 Large-Cap Gainers Last Week (Feb. 16-Feb. 20): Are the Others in Your Portfolio? (Benzinga)
Feb-20-26 03:24PM	Trump Doubles Down On Tariffs After Supreme Court Blow: The Week On Wall Street (Benzinga)
02:09PM	Geopolitical Tensions Resurface Amid Volatile Week (Schaeffer's Research)
11:02AM	Moderna Faces Lawsuit From BioNTech Over Next-Generation COVID-19 Shot (Benzinga)
12:32AM	Moderna's Q4 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Feb-19-26 10:30AM	Moderna Stock Jumps After FDA Reverses Course on Flu Shot (Zacks)
07:00AM	Moderna to Present at Upcoming Conferences in March 2026 (ACCESSWIRE)
06:25AM	Markets Are in the AI Doldrums. Why Trump's Iran Posturing Could Change That. (Barrons.com)
06:15AM	The Moderna Flu-Shot Drama (The Wall Street Journal)
12:01AM	Moderna Spikes After FDAs About-Face on mRNA Flu Vaccine (The Daily Upside)
Feb-18-26 05:21PM	Podcast: Stocks Rise on Chips Momentum (The Wall Street Journal)
05:18PM	Moderna Loses 2 Defenses In Patent Fight (GuruFocus.com)
04:25PM	Moderna Jumps Above 20-Day Moving Average on FDA Flu Vaccine Review. Should You Buy MRNA Stock Here? (Barchart)
04:16PM	These Stocks Are Todays Movers: Nvidia, Palantir, Garmin, Global Payments, Palo Alto, Moderna, Caesars, and More (Barrons.com)
03:57PM	Walmart earnings in focus, Caesars stock surges, Moderna FDA review (Yahoo Finance Video)
03:56PM	Why Moderna (MRNA) Stock Is Trading Up Today (StockStory)
02:30PM	Moderna Stock Rises. FDA Will Review Its Seasonal Flu Vaccine After All. (Barrons.com)
01:54PM	Stocks to Watch Wednesday: Sandisk, Moderna, Caesars, Kenvue (The Wall Street Journal)
01:39PM	In reversal, US FDA will review Moderna's flu vaccine application (Reuters Videos)
01:20PM	FDA Makes U-Turn Again On Moderna New Flu Vaccine Review, Stock Soars (Benzinga)
01:08PM	Moderna says FDA to review its flu vaccine after reversing course (CBS News)
01:01PM	FDA to review Modernas flu jab on agency pivot (Pharmaceutical Technology)
11:20AM	Moderna stock surges as FDA reverses course, agrees to review new flu shot (Yahoo Finance)
11:18AM	Modernas investigational flu vaccine moves forward in FDA review (Proactive)
10:22AM	Moderna got the FDA to change its mind and review its flu vaccine after some concessions (MarketWatch)
10:16AM	Moderna Stock Pops as FDA Application Moves Forward (Schaeffer's Research)
09:45AM	Moderna Says FDA Will Review Flu Vaccine, Reversing Earlier Decision. The Stock Is Rising. (Barrons.com)
09:43AM	Berkshire reduces Apple stake, FDA to review Moderna vaccine (Yahoo Finance Video)
09:27AM	Moderna Says FDA Will Review Its Flu Vaccine. The Stock Is Rising. (Barrons.com)
09:12AM	FDA Reverses Course and Will Now Review Moderna's Flu Shot (The Wall Street Journal)
09:04AM	Moderna Jumps After FDA Reverses Decision On Flu Vaccine (Investor's Business Daily)
Feb-17-26 04:33PM	Stocks Recover on Strength in Apple and Airline Stocks (Barchart)
11:22AM	Market Update: Afternoon Gains for Major Indexes (Barchart)
10:42AM	Moderna Stock Rises After EU Marketing Authorization For mNEXSPIKE (Benzinga)
07:00AM	Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKE (ACCESSWIRE)
Feb-16-26 07:48AM	Moderna's Shares Climb 5.3% as Investors Revisit Biotech Leaders (Zacks)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Klinger Shannon Thyme	Chief Legal Officer	Mar 02 '26	Option Exercise	30.96	13,885	429,880	73,574	Mar 03 04:10 PM
Klinger Shannon Thyme	Chief Legal Officer	Mar 02 '26	Sale	52.29	13,885	726,047	59,689	Mar 03 04:10 PM
Klinger Shannon Thyme	Officer	Mar 02 '26	Proposed Sale	52.29	13,885	726,047		Mar 02 09:56 AM
Hoge Stephen	President	Feb 23 '26	Option Exercise	19.15	160,009	3,064,172	1,617,436	Feb 25 04:49 PM
Hoge Stephen	President	Feb 23 '26	Sale	48.84	160,009	7,814,840	1,457,427	Feb 25 04:49 PM
Hoge Stephen	Officer	Feb 23 '26	Proposed Sale	48.84	160,009	7,814,840		Feb 23 10:26 AM
AFEYAN NOUBAR	Director	Dec 11 '25	Option Exercise	10.90	23,853	259,998	27,777	Dec 15 09:00 AM
AFEYAN NOUBAR	Director	Dec 11 '25	Sale	29.48	23,853	703,306	3,924	Dec 15 09:00 AM
Bancel Stephane	Chief Executive Officer	Dec 11 '25	Option Exercise	10.90	688,073	7,499,996	6,181,970	Dec 15 08:59 AM
Flagship Pioneering Inc.	Affiliate	Dec 11 '25	Proposed Sale	29.49	23,853	703,306		Dec 11 04:30 PM
Hussain Abbas	Director	Dec 09 '25	Sale	27.60	504	13,910	1,515	Dec 11 04:16 PM
Hussain Abbas	Director	Dec 09 '25	Proposed Sale	27.60	504	13,910		Dec 09 10:26 AM
Hussain Abbas	Director	Jun 11 '25	Sale	28.00	312	8,736	580	Jun 12 04:22 PM
Hussain Abbas	Director	Jun 11 '25	Proposed Sale	28.00	312	8,736		Jun 11 10:06 AM

PACB

Pacific Biosciences of California Inc

MRNA

Moderna Inc

Upgrade your FINVIZ experience